| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.03. | Resources Top 5: Tusker charges into African critical minerals as Lodestar eyes Chilean copper | ||
| 12.03. | Closing Bell: ASX resets to Monday levels as IEA strategic oil release fails to curb prices | ||
| 12.03. | The AI problem plaguing law and the company with a $7m fix | ||
| 12.03. | Health Check: The health stocks in the firing line, and those eyeing a promotion | ||
| 12.03. | Lunch Wrap: ASX rattled as oil panic returns, Liontown in the red | ||
| 11.03. | Argonaut Algorithm: How the story is playing out for David Franklyn's favourite gold developers | ||
| 11.03. | 'Accidental' mining legend Norm Seckold shares his secrets to success | ||
| 11.03. | 'SaaS-pocalypse': AI agents rattle software stocks as ASX players position for the shift | ||
| 11.03. | Middle East oil scare turns focus on Australia's domestic energy sources | ||
| 11.03. | Resources Top 6: Extended Lynas Japanese deal sparks rare earths hot streak | ||
| 11.03. | Closing Bell: ASX navigates dangerous waters with no safe harbour in sight | ||
| 11.03. | Lunch Wrap: ASX rides miners as oil swings; Lynas blasts higher | ||
| 11.03. | AI could automate a quarter of all jobs | ||
| 11.03. | Health Check: Rhythm Biosciences is in the groove with first commercial sale of its bowel cancer assay | ||
| 10.03. | GoldArc hits shallow high-grade gold at Whistler | ||
| 10.03. | Orange Minerals unveils multiple polymetallic anomalies at Lennon's Find | ||
| 10.03. | Biocurious: For Bioxyne chief Sam Watson, pot stock success is more than a funky label | ||
| 10.03. | IPO Watch: Kaoko gears up for Namibian copper hunt as ASX listing draws near | ||
| 10.03. | Vital Signs Podcast: Inside Aroa's MASTRR clinical registry | ||
| 10.03. | Resources Top 5: Ressies bounce back from Monday's plunge, Chariot leads the charge | ||
| 10.03. | Hidden travel card costs revealed: what banks don't tell you | ||
| 10.03. | Closing Bell: ASX recovers cautiously as White House offers mixed signals on Iran war | ||
| 10.03. | Lunch Wrap: ASX resurrects as oil backs off amid Trump's war comments | ||
| 10.03. | Health Check: Telix jumps first hurdle with its advanced prostate cancer therapy trial | ||
| 10.03. | Vital Signs Podcast: The gut health ecosystem with Health Food Symmetry |